相关实验视频

Updated: May 5, 2026

Routine Screening Method for Microparticles in Platelet Transfusions

Routine Screening Method for Microparticles in Platelet Transfusions

Published on: January 31, 2018

探索甲状腺功能低下症,平均血小板体积和红细胞分布宽度之间的关联:一个病例对照研究

Mohammed Assaf Almalki¹, Abdullah M Alzahrani^2,3, Loay J Alghamdi¹

¹College of Medicine, King Saud Bin Abdulaziz University for Health Sciences, Jeddah, SAU.

|January 20, 2025

概括

红细胞分布宽度 (RDW) 和平均血小板体积 (MPV) 的增加与甲状腺功能低下有关. 这些血液标记物可能有助于识别甲状腺功能低下症,为临床使用提供进一步研究的理由.

科学领域:

内分泌学在内分泌学.
血液学血液学血液学

背景情况:

甲状腺激素在造血过程中起着至关重要的作用.
红细胞分布宽度 (RDW) 和平均血小板体积 (MPV) 是新兴的炎症标志物.
以前的研究表明,RDW和MPV在甲状腺疾病中的相关性.

研究的目的:

调查甲状腺功能低下症与RDW和MPV水平之间的关联.
评估RDW和MPV作为甲状腺功能低下症指标的潜力.

主要方法:

在2016年5月至2022年6月期间,对阿卜杜拉齐兹国王医疗城 (KAMC-J) 的数据进行了回顾性分析.
99名甲状腺功能低下患者与99名健康对照者的比较.
评估甲状腺功能测试,全血细胞计 (CBC) 和统计分析,包括威尔科克森等级总和测试和ROC曲线分析.

主要成果:

与对照组相比,甲状腺功能下降患者的中位数RDW (14%与13%,p<0.001) 和MPV (10.43 fL与8.9 fL,p<0.001) 显著更高.
MPV水平>9.40 fL显示77%的敏感性和70%的甲状腺功能低下的特异性 (AUC:0.796).
>13%的RDW水平显示,对甲状腺功能低下症有75%的敏感性和51.5%的特异性 (AUC:0.683).

结论:

升高的MPV和RDW水平与甲状腺功能低下症显著相关.
MPV和RDW可以作为潜在的甲状腺功能低下症指标.
需要进一步的研究来确定MPV和RDW作为甲状腺功能低下症查工具的临床实用性.

关键词:

个案控制研究研究.甲状腺功能低下症甲状腺功能低下症血小板的平均体积 (mpv)红细胞分布宽度 (rdw)甲状腺激素甲状腺激素

更多相关视频

Microfluidics in Assessing Platelet Function

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Preparation of Washed Human Platelets for Quantitative Metabolic Flux Studies

Published on: January 10, 2025

相关概念视频

Hyperthyroidism I: Introduction

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...

Graves' Disease I: Introduction

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...